To this point, VEGF-C overexpression in melanoma actually suppresses the de novo priming of CD8+ T cells specifically within tumor-draining lymph nodes, at least in part due to the unique scavenging and cross-presenting capability of lymphatic endothelial cells [64, 75]. The gene discussed is VEGFC; the disease is melanoma.